Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Clinical implementation of routine whole-genome sequencing for hospital infection control of multi-drug resistant pathogens

View ORCID ProfileBrian M Forde, Haakon Bergh, View ORCID ProfileThom Cuddihy, View ORCID ProfileKrispin Hajkowicz, Trish Hurst, E. Geoffrey Playford, View ORCID ProfileBelinda C. Henderson, View ORCID ProfileNaomi Runnegar, View ORCID ProfileJulia Clark, View ORCID ProfileAmy V Jennison, Susan Moss, Anna Hume, View ORCID ProfileHugo Leroux, View ORCID ProfileScott A Beatson, View ORCID ProfileDavid L Paterson, View ORCID ProfilePatrick NA Harris
doi: https://doi.org/10.1101/2022.05.02.22273921
Brian M Forde
1University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brian M Forde
Haakon Bergh
2Central Microbiology, Pathology Queensland, Royal Brisbane & Women’s Hospital, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thom Cuddihy
1University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thom Cuddihy
Krispin Hajkowicz
3Infectious Diseases Unit, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Krispin Hajkowicz
Trish Hurst
3Infectious Diseases Unit, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Geoffrey Playford
4Infection Management Services, Princess Alexandra Hospital, Metro South Hospital and Health Service, Brisbane, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Belinda C. Henderson
4Infection Management Services, Princess Alexandra Hospital, Metro South Hospital and Health Service, Brisbane, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Belinda C. Henderson
Naomi Runnegar
4Infection Management Services, Princess Alexandra Hospital, Metro South Hospital and Health Service, Brisbane, QLD, Australia
5PA-Southside Clinical School, Faculty of Medicine, University of Queensland, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Naomi Runnegar
Julia Clark
6Infection Management and Prevention Service, Queensland Children’s Hospital, Brisbane, QLD, Australia
7Centre for Children’s Health Research, Children’s Health Queensland, Brisbane, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julia Clark
Amy V Jennison
8Public Health Microbiology, Forensic and Scientific Services, Queensland Health, Brisbane, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amy V Jennison
Susan Moss
8Public Health Microbiology, Forensic and Scientific Services, Queensland Health, Brisbane, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Hume
2Central Microbiology, Pathology Queensland, Royal Brisbane & Women’s Hospital, QLD, Australia
3Infectious Diseases Unit, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugo Leroux
9Australian e-Health Research Centre, CSIRO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hugo Leroux
Scott A Beatson
10School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Scott A Beatson
David L Paterson
1University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, QLD, Australia
3Infectious Diseases Unit, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David L Paterson
Patrick NA Harris
1University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, QLD, Australia
2Central Microbiology, Pathology Queensland, Royal Brisbane & Women’s Hospital, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick NA Harris
  • For correspondence: p.harris@uq.edu.au
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Prospective whole-genome sequencing (WGS)-based surveillance may be the optimal approach to rapidly identify transmission of multi-drug resistant (MDR) bacteria in the healthcare setting.

Materials/methods We prospectively collected methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), carbapenem-resistant Acinetobacter baumannii (CRAB), extended-spectrum beta-lactamase (ESBL-E) and carbapenemase-producing Enterobacterales (CPE) isolated from blood cultures, sterile sites or screening specimens across three large tertiary referral hospitals (2 adult, 1 paediatric) in Brisbane, Australia. WGS was used to determine in silico multi-locus sequence typing (MSLT) and resistance gene profiling via a bespoke genomic analysis pipeline. Putative transmission events were identified by comparison of core genome single nucleotide polymorphisms (SNPs). Relevant clinical meta-data were combined with genomic analyses via customised automation, collated into hospital-specific reports regularly distributed to infection control teams.

Results Over four years (April 2017 to July 2021) 2,660 isolates were sequenced. This included MDR gram-negative bacilli (n=293 CPE, n=1309 ESBL), MRSA (n=620) and VRE (n=433). A total of 379 clinical reports were issued. Core genome SNP data identified that 33% of isolates formed 76 distinct clusters. Of the 76 clusters, 43 were contained to the three target hospitals, suggesting ongoing transmission within the clinical environment. The remaining 33 clusters represented possible inter-hospital transmission events or strains circulating in the community. In one hospital, proven negligible transmission of non-multi-resistant MRSA enabled changes to infection control policy.

Conclusions Implementation of routine WGS for MDR pathogens in clinical laboratories is feasible and can enable targeted infection prevention and control interventions.

Summary We initiated a program of routine sequencing of multi-drug resistant organisms. A custom analysis pipeline was used to automate reporting by incorporating clinical meta-data with genomics to define clusters and support infection control interventions.

Competing Interest Statement

P.N.A.H. reports research grants from Merck, Sandoz and Shionogi outside the submitted work has served on advisory boards for Sandoz and Merck and has received speakers fees from Pfizer, Sandoz and Sumitomo. D.L.P reports research grants from Merck, Pfizer and Shionogi outside the submitted work has received honoraria for advisory board membership from Merck, Pfizer, Shionogi, GSK, QPex, Entasis, VenatoRx, BioMerieux and Accelerate. Other authors have no conflicts of interest to declare.

Funding Statement

This work was supported by funding from the Queensland Genomics Health Alliance (now Queensland Genomics), Queensland Health, the Queensland Government. P.N.A.H. was supported by a National Health and Medical Research Council Early Career Fellowship Grant (GNT1157530).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical oversight was provided by The Forensic and Scientific Services Human Ethics Committee (reference HEC17_17) as a Low and Negligible Risk approval, with provision for a waiver of individual patient consent.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 03, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Clinical implementation of routine whole-genome sequencing for hospital infection control of multi-drug resistant pathogens
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinical implementation of routine whole-genome sequencing for hospital infection control of multi-drug resistant pathogens
Brian M Forde, Haakon Bergh, Thom Cuddihy, Krispin Hajkowicz, Trish Hurst, E. Geoffrey Playford, Belinda C. Henderson, Naomi Runnegar, Julia Clark, Amy V Jennison, Susan Moss, Anna Hume, Hugo Leroux, Scott A Beatson, David L Paterson, Patrick NA Harris
medRxiv 2022.05.02.22273921; doi: https://doi.org/10.1101/2022.05.02.22273921
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Clinical implementation of routine whole-genome sequencing for hospital infection control of multi-drug resistant pathogens
Brian M Forde, Haakon Bergh, Thom Cuddihy, Krispin Hajkowicz, Trish Hurst, E. Geoffrey Playford, Belinda C. Henderson, Naomi Runnegar, Julia Clark, Amy V Jennison, Susan Moss, Anna Hume, Hugo Leroux, Scott A Beatson, David L Paterson, Patrick NA Harris
medRxiv 2022.05.02.22273921; doi: https://doi.org/10.1101/2022.05.02.22273921

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8792)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (395)
  • Infectious Diseases (except HIV/AIDS) (10570)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1758)
  • Nursing (103)
  • Nutrition (267)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (220)
  • Psychiatry and Clinical Psychology (1846)
  • Public and Global Health (3989)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (536)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)